Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,560
NCT02608476
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 16, 2015
Completion: Feb 21, 2018
NCT02608450
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
Start: Jan 21, 2016
Completion: Apr 11, 2018
NCT02682264
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
Start: Mar 9, 2016
Completion: Aug 31, 2018
NCT02720627
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
Phase: Phase 2
Start: Oct 28, 2016
Completion: Mar 21, 2018
NCT03665194
A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart
Phase: Phase 1
Start: Jun 6, 2018
Completion: Sep 12, 2018
NCT05910450
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Start: Jun 21, 2023
Completion: Apr 30, 2025
NCT05914805
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Start: Aug 17, 2023
Completion: Mar 31, 2025